Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective study

[1]  Ying Sun,et al.  Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial. , 2012, The Lancet. Oncology.

[2]  F. Al-Mulla,et al.  A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic Resistance , 2012, PloS one.

[3]  V. Mey,et al.  Synergistic cytotoxicity, inhibition of signal transduction pathways and pharmacogenetics of sorafenib and gemcitabine in human NSCLC cell lines. , 2011, Lung cancer.

[4]  O. Rath,et al.  RAF kinase inhibitory protein (RKIP) modulates cell cycle kinetics and motility. , 2011, Molecular bioSystems.

[5]  O. Rath,et al.  Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β. , 2011, Cancer research.

[6]  Q. Pan,et al.  MicroRNA-10b induced by Epstein-Barr virus-encoded latent membrane protein-1 promotes the metastasis of human nasopharyngeal carcinoma cells. , 2010, Cancer letters.

[7]  F. Crea,et al.  Synergistic Cytotoxicity and Molecular Interaction on Drug Targets of Sorafenib and Gemcitabine in Human Pancreas Cancer Cells , 2010, Chemotherapy.

[8]  Zhuchu Chen,et al.  Raf kinase inhibitor protein correlates with sensitivity of nasopharyngeal carcinoma to radiotherapy , 2010, Journal of cellular biochemistry.

[9]  Shaojun Lin,et al.  Prognostic factors of 305 nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy. , 2010, Chinese journal of cancer.

[10]  B. Bonavida,et al.  Viral infection and cancer: the NF-kappaB/Snail/RKIP loop regulates target cell sensitivity to apoptosis by cytotoxic lymphocytes. , 2010, Critical reviews in immunology.

[11]  Zhuchu Chen,et al.  Identification of RKIP as a differentially tyrosine-phosphorylated protein in nasopharyngeal carcinoma and normal nasopharyngeal epithelial tissues by phosphoproteomic approach , 2009, Medical oncology.

[12]  B. Bonavida,et al.  Dysregulation of the cell survival/anti-apoptotic NF-κB pathway by the novel humanized BM-ca anti-CD20 mAb: Implication in chemosensitization , 2009 .

[13]  K. Yeung,et al.  Pivotal roles of snail inhibition and RKIP induction by the proteasome inhibitor NPI-0052 in tumor cell chemoimmunosensitization. , 2009, Cancer research.

[14]  Yan Gao,et al.  Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Breast Cancer , 2009, Molecular Cancer Research.

[15]  A. King,et al.  Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  B. Bonavida,et al.  The activated NF-kappaB-Snail-RKIP circuitry in cancer regulates both the metastatic cascade and resistance to apoptosis by cytotoxic drugs. , 2009, Critical reviews in immunology.

[17]  Zhuchu Chen,et al.  Identification of RKIP as an invasion suppressor protein in nasopharyngeal carcinoma by proteomic analysis. , 2008, Journal of proteome research.

[18]  A. Chinnaiyan,et al.  Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[19]  S. Liang,et al.  Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china. , 2008, International journal of radiation oncology, biology, physics.

[20]  Yan Gao,et al.  Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Epithelial Ovarian Cancer , 2008, Molecular Cancer Research.

[21]  J. Jass,et al.  Multimarker phenotype predicts adverse survival in patients with lymph node‐negative colorectal cancer , 2008, Cancer.

[22]  Yulan He,et al.  Downregulated NM23-H1 expression is associated with intracranial invasion of nasopharyngeal carcinoma , 2008, British Journal of Cancer.

[23]  Xiao Zhi-qiang.  Effects of RKIP on the proliferation of nasopharyngeal carcinoma cells , 2008 .

[24]  J. Jass,et al.  Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer. , 2007, American journal of clinical pathology.

[25]  W. Kolch,et al.  Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  Xiang Guo,et al.  Elevated plasma big ET‐1 is associated with distant failure in patients with advanced‐stage nasopharyngeal carcinoma , 2006, Cancer.

[27]  Y. Liao,et al.  [Expression clinical significance of nm23-H1 and vessel endothelium growth factor protein in nasopharyngeal carcinoma]. , 2006, Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery.

[28]  Karin Oien,et al.  Reduction of Raf-1 Kinase Inhibitor Protein Expression Correlates with Breast Cancer Metastasis , 2005, Clinical Cancer Research.

[29]  A. Bosserhoff,et al.  Reduction in Raf Kinase Inhibitor Protein Expression Is Associated with Increased Ras-Extracellular Signal-Regulated Kinase Signaling in Melanoma Cell Lines , 2004, Cancer Research.

[30]  J. Sham,et al.  Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy. , 2004, International journal of radiation oncology, biology, physics.

[31]  B. Aggarwal,et al.  RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced Apoptosis* , 2004, Journal of Biological Chemistry.

[32]  M. Rubin,et al.  Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis , 2003 .